{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:44:48Z","timestamp":1775659488510,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2635-E-241-002"],"award-info":[{"award-number":["MOST 107-2635-E-241-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2635-E-241-002"],"award-info":[{"award-number":["MOST 107-2635-E-241-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005057","name":"National Tsing Hua University","doi-asserted-by":"publisher","award":["105N522CE1"],"award-info":[{"award-number":["105N522CE1"]}],"id":[{"id":"10.13039\/501100005057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) is an emerging epidemic worldwide and is regarded as a hepatic manifestation of metabolic syndrome (MetS). Only a few studies have discussed the biological features associated with quantitative assessment of ultrasound for characterizing NAFLD. Our aim was to delineate relevant metabolic characteristics using a new quantitative tool, the ultrasound quantitative diagnostic index (QDI). A total of 394 ultrasound data were analyzed to extract texture-feature parameters, the signal-to-noise ratio (SNR), and the slope of the center frequency downshift (CFDS) for determining the QDI. The texture index, SNR, and CFDS slope were all negatively correlated with high-density lipoprotein and positively correlated with other anthropometric indices and metabolic factors (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The SNR had the greatest contribution to anthropometric and biochemical factors, followed by the texture index and CFDS slope. An increase in 1 unit of QDI score engendered a 9% higher risk of MetS, reflecting that the tool is feasible for use in identifying MetS (area under the receiver operating characteristic curve: 0.89). The QDI was correlated with metabolic factors and an independent predictor for MetS. Thus, this QDI might be a feasible method for use in clinical surveillance, epidemiology research, and metabolic function evaluations in patients with NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-019-44453-3","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:04:40Z","timestamp":1559037880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Yin-Yin","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Kuang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsiang","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuen-Cheh","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"44453_CR1","first-page":"11","volume":"2","author":"AS Yu","year":"2002","unstructured":"Yu, A. S. & Keeffe, E. B. Nonalcoholic fatty liver disease. Rev. Gastroenterol. Disord. 2, 11\u20139 (2002).","journal-title":"Rev. Gastroenterol. Disord."},{"key":"44453_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","volume":"29","author":"NC Leite","year":"2009","unstructured":"Leite, N. C., Salles, G. F., Araujo, A. L., Villela-Nogueira, C. A. & Cardoso, C. R. Prevalence and associated factors of nonalcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int. 29, 113\u2013119 (2009).","journal-title":"Liver Int."},{"key":"44453_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679\u2013689 (2010).","journal-title":"Hepatology"},{"key":"44453_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","volume":"20","author":"Y Sumida","year":"2014","unstructured":"Sumida, Y., Nakajima, A. & Itoh, Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J. Gastroenterol. 20, 475\u2013485 (2014).","journal-title":"World J. Gastroenterol."},{"key":"44453_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMra1610570","volume":"377","author":"EB Tapper","year":"2017","unstructured":"Tapper, E. B. & Lok, A. S. Use of liver imaging and biopsy in clinical practice. N. Engl. J. Med. 377, 756\u2013768 (2017).","journal-title":"N. Engl. J. Med."},{"key":"44453_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/liv.13658","volume":"38","author":"L Castera","year":"2018","unstructured":"Castera, L. Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: Non-invasive tests are enough. Liver Int. 38, 67\u201370 (2018).","journal-title":"Liver Int."},{"key":"44453_CR7","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3748\/wjg.14.3476","volume":"14","author":"SR Mehta","year":"2008","unstructured":"Mehta, S. R., Thomas, E. L., Bell, J. D., Johnston, D. G. & Taylor-Robinson, S. D. Non-invasive means of measuring hepatic fat content. World J. Gastroenterol. 14, 3476\u20133483 (2008).","journal-title":"World J. Gastroenterol."},{"key":"44453_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","volume":"58","author":"MV Machado","year":"2013","unstructured":"Machado, M. V. & Cortez-Pinto, H. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. J. Hepatol. 58, 1007\u20131019 (2013).","journal-title":"J. Hepatol."},{"key":"44453_CR9","doi-asserted-by":"publisher","first-page":"e76813","DOI":"10.1371\/journal.pone.0076813","volume":"8","author":"S Siegert","year":"2013","unstructured":"Siegert, S. et al. Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers. PLoS One 8, e76813 (2013).","journal-title":"PLoS One"},{"key":"44453_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/liv.13682","volume":"38","author":"P Marcellin","year":"2018","unstructured":"Marcellin, P. & Kutala, B. K. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 38, 2\u20136 (2018).","journal-title":"Liver Int."},{"key":"44453_CR11","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak, L. S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462\u2013468 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"44453_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.diabet.2013.01.007","volume":"39","author":"PH Ducluzeau","year":"2013","unstructured":"Ducluzeau, P. H. et al. MRI measurement of liver fat content predicts the metabolic syndrome. Diabetes Metab. 39, 314\u2013321 (2013).","journal-title":"Diabetes Metab."},{"key":"44453_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).","journal-title":"BMC Gastroenterol."},{"key":"44453_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"Hamaguchi, M. et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J. Gastroenterol. 18, 1508\u20131516 (2012).","journal-title":"World J. Gastroenterol."},{"key":"44453_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/liv.12454","volume":"34","author":"NH Kim","year":"2014","unstructured":"Kim, N. H. et al. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects. Liver Int. 34, 604\u2013611 (2014).","journal-title":"Liver Int."},{"key":"44453_CR16","doi-asserted-by":"publisher","first-page":"e0120443","DOI":"10.1371\/journal.pone.0120443","volume":"10","author":"BL Yang","year":"2015","unstructured":"Yang, B. L. et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS One 10, e0120443 (2015).","journal-title":"PLoS One"},{"key":"44453_CR17","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.ultrasmedbio.2004.08.001","volume":"30","author":"D Gaitini","year":"2004","unstructured":"Gaitini, D. et al. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. Ultrasound Med. Biol. 30, 1321\u20131327 (2004).","journal-title":"Ultrasound Med. Biol."},{"key":"44453_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/oby.2011.302","volume":"20","author":"MF Xia","year":"2012","unstructured":"Xia, M. F. et al. Standardized ultrasound hepatic\/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity 20, 444\u2013452 (2012).","journal-title":"Obesity"},{"key":"44453_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ultrasmedbio.2012.10.021","volume":"39","author":"Y Kanayama","year":"2013","unstructured":"Kanayama, Y., Kamiyama, N., Maruyama, K. & Sumino, Y. Real-time ultrasound attenuation imaging of diffuse fatty liver disease. Ultrasound Med. Biol. 39, 692\u2013705 (2013).","journal-title":"Ultrasound Med. Biol."},{"key":"44453_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/e18090341","volume":"18","author":"PH Tsui","year":"2016","unstructured":"Tsui, P. H. & Wan, Y. L. Effects of fatty infiltration of the liver on the Shannon entropy of ultrasound backscattered signals. Entropy 18, 341 (2016).","journal-title":"Entropy"},{"key":"44453_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep35083","volume":"6","author":"YY Liao","year":"2016","unstructured":"Liao, Y. Y. et al. Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease. Sci. Rep. 6, 35083 (2016).","journal-title":"Sci. Rep."},{"key":"44453_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15171\/mejdd.2016.18","volume":"8","author":"MR Fattahi","year":"2016","unstructured":"Fattahi, M. R., Niknam, R., Safarpour, A., Sepeh-rimanesh, M. & Lotfi, M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East. J. Dig. Dis. 8, 131\u2013137 (2016).","journal-title":"Middle East. J. Dig. Dis."},{"key":"44453_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/hep.28746","volume":"64","author":"S Sookoian","year":"2016","unstructured":"Sookoian, S. & Pirola, C. J. Nonalcoholic fatty liver disease and metabolic syndrome: shared genetic basis of pathogenesis. Hepatology 64, 1417\u20131420 (2016).","journal-title":"Hepatology"},{"key":"44453_CR24","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi, M. et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 102, 2708\u20132715 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"44453_CR25","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","volume":"32","author":"S Ballestri","year":"2012","unstructured":"Ballestri, S. et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int. 32, 1242\u20131252 (2012).","journal-title":"Liver Int."},{"key":"44453_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang, K. C. et al. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci. Rep. 6, 27034 (2016).","journal-title":"Sci. Rep."},{"key":"44453_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1386-5056(99)00010-6","volume":"55","author":"AM Badawi","year":"1999","unstructured":"Badawi, A. M., Derbala, A. S. & Youssef, A. M. Fuzzy logic algorithm for quantitative tissue characterization of diffuse liver diseases from ultrasound images. Int. J. Med. Inform. 55, 135\u2013147 (1999).","journal-title":"Int. J. Med. Inform."},{"key":"44453_CR28","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1118\/1.4725759","volume":"39","author":"UR Acharya","year":"2012","unstructured":"Acharya, U. R. et al. Data mining framework for fatty liver disease classification in ultrasound: a hybrid feature extraction paradigm. Med. Phys. 39, 4255\u20134264 (2012).","journal-title":"Med. Phys."},{"key":"44453_CR29","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","volume":"13","author":"SC Lin","year":"2015","unstructured":"Lin, S. C. et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin. Gastroenterol. Hepatol. 13, 1337\u20131345 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"44453_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1109\/58.842062","volume":"47","author":"PM Shankar","year":"2000","unstructured":"Shankar, P. M. A general statistical model for ultrasonic backscattering from tissues. IEEE Trans. Ultrason. Ferroelec. Freq. Contr. 47, 727\u2013736 (2000).","journal-title":"IEEE Trans. Ultrason. Ferroelec. Freq. Contr."},{"key":"44453_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/epirev\/mxm002","volume":"29","author":"MU Jakobsen","year":"2007","unstructured":"Jakobsen, M. U., Berentzen, T., S\u00f8rensen, T. I. & Overvad, K. Abdominal obesity and fatty liver. Epidemiol. Rev. 29, 77\u201387 (2007).","journal-title":"Epidemiol. Rev."},{"key":"44453_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/met.2017.0001","volume":"15","author":"YH Ko","year":"2017","unstructured":"Ko, Y. H., Wong, T. C., Hsu, Y. Y., Kuo, K. L. & Yang, S. H. The correlation between body fat, visceral fat, and nonalcoholic fatty liver disease. Metab. Syndr. Relat. Disord. 15, 304\u2013311 (2017).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"44453_CR33","first-page":"123","volume":"2","author":"AA Spector","year":"1984","unstructured":"Spector, A. A. Plasma lipid transport. Clin. Physiol. Biochem. 2, 123\u2013134 (1984).","journal-title":"Clin. Physiol. Biochem."},{"key":"44453_CR34","doi-asserted-by":"publisher","first-page":"783976","DOI":"10.1155\/2011\/783976","volume":"2011","author":"K Fon-Tacer","year":"2011","unstructured":"Fon-Tacer, K. & Rozman, D. Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids 2011, 783976 (2011).","journal-title":"J. Lipids"},{"key":"44453_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/br.2014.309","volume":"2","author":"M Tomizawa","year":"2014","unstructured":"Tomizawa, M. et al. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed. Rep. 2, 633\u2013636 (2014).","journal-title":"Biomed. Rep."},{"key":"44453_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","volume":"107","author":"G Marchesini","year":"1999","unstructured":"Marchesini, G. et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450\u2013455 (1999).","journal-title":"Am. J. Med."},{"key":"44453_CR37","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider, K. M. & Kahn, S. E. The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91, 4753\u20134761 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"44453_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0301-5629(97)00041-0","volume":"23","author":"FM Valckx","year":"1997","unstructured":"Valckx, F. M. & Thijssen, J. M. Characterization of echographic image texture by co-occurrence matrix parameters. Ultrasound Med. Biol. 23, 559\u2013571 (1997).","journal-title":"Ultrasound Med. Biol."},{"key":"44453_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.7150\/ijbs.5.474","volume":"5","author":"TF Daniels","year":"2009","unstructured":"Daniels, T. F., Killinger, K. M., Michal, J. J., Wright, R. W. & Jiang, Z. Lipoproteins, cholesterol homeostasis and cardiac health. Int. J. Biol. Sci. 5, 474\u2013488 (2009).","journal-title":"Int. J. Biol. Sci."},{"key":"44453_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0032-1306423","volume":"32","author":"H Chatrath","year":"2012","unstructured":"Chatrath, H., Vuppalanchi, R. & Chalasani, N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin. Liver Dis. 32, 22\u201329 (2012).","journal-title":"Semin. Liver Dis."},{"key":"44453_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/1874091X01206010078","volume":"6","author":"E Eren","year":"2012","unstructured":"Eren, E., Yilmaz, N. & Aydin, O. High density lipoprotein and it\u2019s dysfunction. Open Biochem. J. 6, 78\u201393 (2012).","journal-title":"Open Biochem. J."},{"key":"44453_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ 172, 367\u2013379 (2005).","journal-title":"CMAJ"},{"key":"44453_CR43","doi-asserted-by":"publisher","first-page":"g4596","DOI":"10.1136\/bmj.g4596","volume":"349","author":"N Sattar","year":"2014","unstructured":"Sattar, N., Forrest, E. & Preiss, D. Non-alcoholic fatty liver disease. BMJ 349, g4596 (2014).","journal-title":"BMJ"},{"key":"44453_CR44","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/jc.2005-2774","volume":"91","author":"TL Setji","year":"2006","unstructured":"Setji, T. L. et al. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 1741\u20131747 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"44453_CR45","doi-asserted-by":"publisher","first-page":"e85366","DOI":"10.1371\/journal.pone.0085366","volume":"9","author":"ZG Jiang","year":"2014","unstructured":"Jiang, Z. G., Mukamal, K., Tapper, E., Robson, S. C. & Tsugawa, Y. Low LDL-C and high HDL-C levels are associated with elevated serum transaminases amongst adults in the United States: a cross-sectional study. PLoS One 9, e85366 (2014).","journal-title":"PLoS One"},{"key":"44453_CR46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1121\/1.1912685","volume":"50","author":"H Pauly","year":"1971","unstructured":"Pauly, H. & Schwan, H. P. Mechanism of absorption of ultrasound in liver tissue. J. Acoust. Soc. Am. 50, 692\u2013699 (1971).","journal-title":"J. Acoust. Soc. Am."},{"key":"44453_CR47","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377, 2063\u20132072 (2017).","journal-title":"N. Engl. J. Med."},{"key":"44453_CR48","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 66, 1138\u20131153 (2017).","journal-title":"Gut."},{"key":"44453_CR49","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan, J. G., Kim, S. U. & Wong, V. W. New trends on obesity and NAFLD in Asia. J. Hepatol. 67, 862\u2013873 (2017).","journal-title":"J. Hepatol."},{"key":"44453_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman, Y. & Sanyal, A. J. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut. 66, 180\u2013190 (2017).","journal-title":"Gut."},{"key":"44453_CR51","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jdiacomp.2016.05.014","volume":"30","author":"I Mikolasevic","year":"2016","unstructured":"Mikolasevic, I. et al. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome. J. Diabetes Complic. 30, 1347\u20131353 (2016).","journal-title":"J. Diabetes Complic."},{"key":"44453_CR52","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/e20120893","volume":"20","author":"YH Lin","year":"2018","unstructured":"Lin, Y. H., Liao, Y. Y., Yeh, C. K., Yang, K. C. & Tsui, P. H. Ultrasound entropy imaging of nonalcoholic fatty liver disease: association with metabolic syndrome. entropy 20, 893 (2018).","journal-title":"entropy"},{"key":"44453_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/e18090341","volume":"18","author":"PH Tsui","year":"2016","unstructured":"Tsui, P. H. & Wan, Y. L. Effects of Fatty In ltration of the Liver on the Shannon Entropy of Ultrasound Backscattered Signals. Entropy 18, 341 (2016).","journal-title":"Entropy"},{"issue":"4","key":"44453_CR54","doi-asserted-by":"publisher","first-page":"546","DOI":"10.21037\/qims.2019.03.14","volume":"9","author":"Kuen Cheh Yang","year":"2019","unstructured":"Yang, K. C., Liao, Y. Y., Tsui, P. H. & Yeh, C. K. Ultrasound imaging in nonalcoholic liver disease: current applications and future developments. Quant. Imaging Med. Surg., https:\/\/doi.org\/10.21037\/qims.2019.03.14 (2019).","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"44453_CR55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/app9040661","volume":"9","author":"Z Zhou","year":"2019","unstructured":"Zhou, Z., Zhang, Q., Wu, W., Wu, S. & Tsui, P. H. Hepatic Steatosis Assessment Using Quantitative Ultrasound Parametric Imaging Based on Backscatter Envelope Statistics. Appl Sci 9, 661 (2019).","journal-title":"Appl Sci"},{"key":"44453_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep08766","volume":"5","author":"K Zhang","year":"2015","unstructured":"Zhang, K., Chen, H. & Guo, X. Double-scattering\/reflection in a single nanoparticle for intensified ultrasound imaging. Sci. Rep. 5, 8766 (2015).","journal-title":"Sci. Rep."},{"key":"44453_CR57","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3109\/00365521.2016.1172336","volume":"51","author":"P Nasr","year":"2016","unstructured":"Nasr, P., Hilliges, A., Thorelius, L., Kechagias, S. & Ekstedt, M. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scand. J. Gastroenterol. 51, 1126\u20131132 (2016).","journal-title":"Scand. J. Gastroenterol."},{"key":"44453_CR58","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/acsbiomaterials.7b00779","volume":"4","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Zhang, K., Xua, Y. H. & Chen, H. R. Nanosized hollow colloidal organosilica nanospheres with high elasticity for contrast-enhanced ultrasonography of tumors. ACS Biomater. Sci. Eng. 4, 248\u2013256 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"44453_CR59","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1872-034X.2007.00130.x","volume":"37","author":"H Iijima","year":"2007","unstructured":"Iijima, H. et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol. Res. 37, 722\u2013730 (2007).","journal-title":"Hepatol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44453-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:58:07Z","timestamp":1671271087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44453"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44453-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7922"}}